ContractDistribution Agreement • March 16th, 2006 • Andrx Corp /De/ • Pharmaceutical preparations • New York
Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
Parent Andrx Corporation, a Delaware Corporation SubsidiariesAndrx Corp /De/ • March 16th, 2006 • Pharmaceutical preparations
Anda, Inc., a Florida Corporation Anda Marketing, Inc., a Florida Corporation Anda Pharmaceuticals, Inc., a Florida Corporation Anda Puerto Rico, Inc., a Puerto Rico Corporation Anda Veterinary Supply, Inc., a Florida Corporation Andrx EU Limited, a UK company Andrx Laboratories (NJ), Inc., a Delaware corporation Andrx Labs, LLC, a Delaware LLC Andrx Management Corporation, a Florida Corporation Andrx Pharmaceuticals, Inc., a Florida Corporation Andrx Pharmaceuticals, LLC, a Delaware LLC Andrx Pharmaceuticals Equipment #1, LLC, a Florida LLC Andrx Pharmaceuticals (MASS), Inc. a Florida corporation Andrx Pharmaceuticals (NC), Inc., a Florida corporation Andrx Pharmaceuticals (NC) Equipment, LLC, a Delaware LLC Andrx Pharmaceuticals Sales and Marketing, Inc. a Florida corporation Andrx South Carolina I, Inc., a South Carolina corporation Andrx Therapeutics, Inc., a Florida corporation Caran Pharmaceuticals, Inc., a Nevada Corporation Cybear LLC, a Delaware LLC RxAPS,
SUPPLY AGREEMENTSupply Agreement • March 16th, 2006 • Andrx Corp /De/ • Pharmaceutical preparations • New York
This Supply Agreement (“Agreement”) is dated as of the 4th day of September, 2003 by and between Andrx Pharmaceuticals, Inc., a Florida Corporation (“hereinafter referred to as “ANDRX”) with offices located at 4955 Orange Dr., Davie, FL, 33314 and Pfizer Inc., a Delaware corporation (hereinafter referred to as “PFIZER”), with offices located at 235 East 42nd Street, New York, New York l0017-5755.
